Journey Medical Corporation Company Profile
NASDAQ: DERMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Journey Medical at a glance
Journey Medical Corporation (NASDAQ: DERM) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Scottsdale, AZ. Journey Medical is led by Mr. Claude Maraoui and employs about 58 people. The company's shares have traded publicly since 2021.
At a market capitalization of $93.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001867066, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Journey Medical do?
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Business description based on the company's public filings.
Company information
- Legal name
- Journey Medical Corporation
- Ticker
- NASDAQ: DERM
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Claude Maraoui
- Employees
- 58
- Headquarters
- 9237 East Via de Ventura Blvd., Scottsdale, AZ, United States
- Phone
- 480 434 6670
- Website
- journeymedicalcorp.com
- IPO year
- 2021
- Market cap
- $93.16M
- SEC CIK
- 0001867066
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to Journey Medical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CLLSCellectis S.A. ADR | 0.9209 | -7.89% | $92.76M | vs DERM |
| CATXPerspective Therapeutics Inc. | 0.7538 | -3.85% | $91.03M | vs DERM |
| NRXPNRX Pharmaceuticals Inc. | 2.15 | -15.69% | $95.31M | vs DERM |
| PDSBPDS Biotechnology Corporation | 0.7774 | -3.70% | $95.39M | vs DERM |
| NTHINeOnc Technologies Holdings Inc. | 3.15 | -9.48% | $90.88M | vs DERM |
| NBPNovaBridge Biosciences ADR | 0.83 | -5.66% | $96.28M | vs DERM |
| UNCYUnicycive Therapeutics Inc. | 3.35 | -5.10% | $97.77M | vs DERM |
| CPIXCumberland Pharmaceuticals Inc. | 5.84 | -7.30% | $87.57M | vs DERM |